Narus Financial Partners LLC Sells 663 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Narus Financial Partners LLC lowered its stake in HealthEquity, Inc. (NASDAQ:HQY) by 10.1% during the fourth quarter, Holdings Channel reports. The institutional investor owned 5,870 shares of the company’s stock after selling 663 shares during the period. Narus Financial Partners LLC’s holdings in HealthEquity were worth $563,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Raymond James Trust N.A. grew its position in shares of HealthEquity by 4.8% in the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock valued at $238,000 after purchasing an additional 132 shares during the last quarter. UMB Bank n.a. grew its holdings in HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after buying an additional 164 shares in the last quarter. Truist Financial Corp increased its position in HealthEquity by 7.0% during the 2nd quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock worth $247,000 after buying an additional 188 shares during the period. Elk River Wealth Management LLC lifted its holdings in shares of HealthEquity by 0.3% during the third quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company’s stock worth $5,417,000 after buying an additional 217 shares in the last quarter. Finally, Nicolet Advisory Services LLC grew its position in shares of HealthEquity by 5.8% during the 3rd quarter. Nicolet Advisory Services LLC now owns 4,218 shares of the company’s stock worth $330,000 after purchasing an additional 233 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

HealthEquity Price Performance

HQY stock opened at $110.57 on Friday. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $111.36. The stock has a market capitalization of $9.58 billion, a PE ratio of 101.44, a price-to-earnings-growth ratio of 1.91 and a beta of 0.54. The company’s 50-day moving average is $99.97 and its 200-day moving average is $88.17. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period last year, the firm posted $0.40 earnings per share. Equities research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on HQY. Barrington Research lifted their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Monday, December 2nd. Mizuho initiated coverage on HealthEquity in a report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target on the stock. Royal Bank of Canada upped their price objective on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. The Goldman Sachs Group assumed coverage on shares of HealthEquity in a research report on Friday, November 15th. They set a “neutral” rating and a $108.00 target price on the stock. Finally, JMP Securities upped their price target on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research report on Tuesday, December 10th. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, HealthEquity presently has an average rating of “Moderate Buy” and a consensus target price of $110.71.

Insider Transactions at HealthEquity

In related news, Director Stuart B. Parker sold 25,000 shares of the firm’s stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the transaction, the director now directly owns 19,061 shares of the company’s stock, valued at $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Frank Corvino sold 1,039 shares of the stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total transaction of $99,847.90. Following the completion of the sale, the director now owns 3,784 shares of the company’s stock, valued at approximately $363,642.40. This trade represents a 21.54 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 34,289 shares of company stock valued at $3,355,718 over the last three months. Corporate insiders own 2.20% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.